Genprex, Inc. (GNPX) Form 8-K — Jul 30, 2026
Genprex, Inc. announced that the Nasdaq Hearings Panel has granted an exception allowing the company to maintain its listing on The Nasdaq Capital Market despite failing to meet the minimum bid price requirement. To retain its listing, the company must maintain a closing bid price of at least $1.00 per share for every trading day through December 7, 2026, while the Panel retains jurisdiction over the matter. The company implemented a one-for-twenty-two reverse stock split effective July 16, 2026, in an effort to demonstrate compliance with the $1.00 bid price rule.
Key figures
- Compliance deadline
- December 7, 2026
- Reverse split ratio
- 1:22
- Bid price requirement usd
- 1.00
- Minimum stockholders equity usd
- 2.5 million
- Market value delisting threshold usd
- 5 million
Price after filing
Close on the filing date to close N calendar days later (from $6.06). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.